Laura Williams
Vermögen: 2 Mio $ am 31.07.2026
Vermögen: 2 Mio $ am 31.07.2026
Laura A. Williams is Chief Patient Officer at Ardelyx, Inc. since 2025.
Formerly, Dr. Williams was Independent Director at Imara, Inc. from 2021 to 2023, Senior Vice President-Clinical Development at AMAG Pharmaceuticals, Inc. from 2017 to 2020, and Vice President-Clinical Development at Myovant Sciences, Inc. from 2016 to 2017.
Education includes graduate studies at the University of Washington, undergraduate studies at Mississippi State University, and a doctorate from the University of Iowa.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
ARDELYX, INC. 0,15 % | 18.06.2026 | 378.195 ( 0,15 % ) | 2 Mio $ | 31.07.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| ARDELYX, INC. | Corporate Officer/Principal | 01.01.2025 |
| Unternehmen | Position | Ende |
|---|---|---|
| IMARA | Direktor/Vorstandsmitglied | 01.02.2023 |
| AMAG PHARMACEUTICALS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2020 |
Myovant Sciences, Inc.
Myovant Sciences, Inc. Medical SpecialtiesHealth Technology Develops therapeutics for women''s health and prostate cancer | Technik-/Wissenschafts-/F&E-Leiter | 01.08.2017 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 7 |
|---|---|
University of Washington
University of Washington Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Mississippi State University
Mississippi State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Iowa
University of Iowa Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AMAG Pharmaceuticals, Inc.
AMAG Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Ardelyx, Inc.
Ardelyx, Inc. Pharmaceuticals: MajorHealth Technology Discovers and Develops therapeutic therapeutic drugs that work in the gastrointestinal tract to treat cardio-renal, GI and metabolic diseases | Health Technology |
Imara, Inc.
Imara, Inc. Pharmaceuticals: MajorHealth Technology Develops and distributes novel therapeutics for patients with sickle cell disease | Health Technology |
Myovant Sciences, Inc.
Myovant Sciences, Inc. Medical SpecialtiesHealth Technology Develops therapeutics for women''s health and prostate cancer | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen